🇺🇸 FDA
Patent

US 6162897

17q-linked breast and ovarian cancer susceptibility gene

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6162897 (17q-linked breast and ovarian cancer susceptibility gene) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00, A61K48/00